The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.
In recent years, FAP-targeted imaging has emerged as a highly-promising modality as a pan-cancer agent.
APA
Novruzov E, Mamlins E, et al. (2025). The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.. Seminars in nuclear medicine, 55(5), 724-733. https://doi.org/10.1053/j.semnuclmed.2025.07.001
MLA
Novruzov E, et al.. "The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma.." Seminars in nuclear medicine, vol. 55, no. 5, 2025, pp. 724-733.
PMID
40683830
Abstract
In recent years, FAP-targeted imaging has emerged as a highly-promising modality as a pan-cancer agent. Until now, several studies and review articles have focused on efficacy of FAPI imaging in epithelial malignancies with a high global incidence and prevalence such as lung cancer or GI-tumors. This work sought to shed light on diagnostic performance and clinical impact of FAPI imaging in rather low-incidence tumor-entities, which are nevertheless characterized by a poor outcome.
MeSH Terms
Humans; Positron-Emission Tomography; Serine Endopeptidases; Membrane Proteins; Endopeptidases; Fibroblast Activation Protein Alpha
같은 제1저자의 인용 많은 논문 (3)
- Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial Carcinoma.
- The analysis of biodistribution and tumor uptake of [F]AlF-FAPI-74 in patients with soft tissue sarcoma and gastro-intestinal tumors compared with [F]FDG in a prospective, exploratory study.
- Enhancing reader confidence through dual-time imaging and alternative reconstruction algorithms with [F]PSMA-1007 PET/CT imaging in local relapsed castration-sensitive prostate cancer?